Towards safer risperidone prescribing in Alzheimer’s disease

Suzanne Reeves, Julie Bertrand, Hiroyuki Uchida, Kazunari Yoshida, Yohei Otani, Mikail Ozer, Kathy Y Liu, Elvira Bramon, Robert Bies, Bruce Pollock, Robert Howard
doi: https://doi.org/10.1101/2020.08.12.20173310

Article usage

Article usage: August 2020 to October 2024

AbstractFullPdf
Aug 2020473086
Sep 2020115055
Oct 202076038
Nov 202066045
Dec 2020123049
Jan 2021159049
Feb 2021256036
Mar 202180929
Apr 202189216
May 202170314
Jun 202172112
Jul 202133311
Aug 202129415
Sep 202137018
Oct 202146527
Nov 202128894
Dec 20212429
Jan 2022271120
Feb 202231614
Mar 2022463197
Apr 202213410
May 202213310
Jun 20221014
Jul 20221422
Aug 20221269
Sep 20223028
Oct 20221736
Nov 20221545
Dec 202214107
Jan 2023171110
Feb 202311127
Mar 20238151
Apr 202333179
May 202311177
Jun 202313116
Jul 2023844
Aug 2023161712
Sep 2023172417
Oct 202310130
Nov 2023786
Dec 2023731
Jan 20241451
Feb 20241084
Mar 2024989
Apr 20241069
May 2024866
Jun 20241289
Jul 20241665
Aug 20241229
Sep 202411415
Oct 2024131210
Back to top
Posted August 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Towards safer risperidone prescribing in Alzheimer’s disease
Suzanne Reeves, Julie Bertrand, Hiroyuki Uchida, Kazunari Yoshida, Yohei Otani, Mikail Ozer, Kathy Y Liu, Elvira Bramon, Robert Bies, Bruce Pollock, Robert Howard
medRxiv 2020.08.12.20173310; doi: https://doi.org/10.1101/2020.08.12.20173310
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area